There is mounting evidence that the Epstein-Barr virus may play a part in causing autoimmune diseases like multiple sclerosis. But one puzzle remains: almost everyone gets this virus early in life, yet only a few people ever go on to develop multiple sclerosis.
Now, a team led by Dr. Nicholas Sanderson and Professor Tobias Derfuss at the Department of Biomedicine of the University of Basel and the University Hospital Basel, report new evidence in Cell that helps resolve this puzzle. Working at the interface of clinical neurology and basic immunology, the researchers focused on B cells—a type of immune cell best known for producing antibodies.